Gloucester Pharmaceuticals - About the company
Gloucester Pharmaceuticals is an acquired company based in Cambridge (United States), founded in 2002. It operates as a Developer of drugs for the treatment of cancer. Gloucester Pharmaceuticals has raised $33M in funding from Novo Holdings. The company has 3186 active competitors, including 1090 funded and 762 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Kite Pharma.
Company Details
Developer of drugs for the treatment of cancer. Gloucester’s first compound, romidepsin, is a late-stage oncology drug candidate that has shown potential activity across a range of hematological malignancies. The company retains worldwide exclusive rights to romidepsin, an oncology candidate within a new class of anti-cancer agents known as histone deacetylase (HDAC) inhibitors. Preclinical studies suggest that romidepsin is a potent inhibitor of Class I, Class II, and Class IV HDACs
Key Metrics
Founded Year
2002
Location
Cambridge, United States
Stage
Acquired
Total Funding
$33M in 6 rounds
Latest Funding Round
Investors
Ranked
656th among 3186 active competitors
Similar Companies
Exit Details
Acquired by Celgene (Dec 07, 2009)
Legal entities associated with Gloucester Pharmaceuticals
Gloucester Pharmaceuticals is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Gloucester Pharmaceuticals Inc CIN: 020686709 , United States, Active | Dec 31, 2001 | - | - | - |
Gloucester Pharmaceuticals's acquisition details
Gloucester Pharmaceuticals got acquired by Celgene on Dec 07, 2009 at an acquisition amount of $*****.
Click here to take a look at Gloucester Pharmaceuticals's acquisition in detail
Sign up to download Gloucester Pharmaceuticals' company profile
Gloucester Pharmaceuticals's funding and investors
Gloucester Pharmaceuticals has raised a total funding of $33M over 6 rounds. Its latest funding round was a Series D round on Aug 25, 2009 for $*****. 5 investors participated in its latest round. Gloucester Pharmaceuticals has 5 institutional investors.
Here is the list of recent funding rounds of Gloucester Pharmaceuticals:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 25, 2009 | 8510882 | Series D | 2261312 | 4838498 | 8387339 | 5182803 |
Aug 05, 2009 | 9801177 | Seed | 5811046 | 4154417 | 5652411 | 1457092 |
Jul 15, 2009 | 9369835 | Seed | 9892015 | 2435943 | 5635373 | 8393404 |
Access funding benchmarks and valuations. Sign up today!View details of Gloucester Pharmaceuticals's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Gloucester Pharmaceuticals's Competitors and alternates
Top competitors of Gloucester Pharmaceuticals include Jazz Pharmaceuticals, Sana Biotechnology and Kite Pharma. Here is the list of Top 10 competitors of Gloucester Pharmaceuticals, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of genetically engineered cell therapies for multiple disorders | $821M | 75/100 | |
3rd | Kite Pharma 2009, Los Angeles (United States), Acquired | Developer of cancer immunotherapy products using genetic engineering | $97.7M | 75/100 | |
4th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 74/100 | |
5th | Juno Therapeutics 2013, Seattle (United States), Acquired | Global biopharmaceutical company discovering, developing, and delivering innovative medicines | $317M | 74/100 | |
6th |  Advanced Accelerator Applications 2002, Saint Genis Pouilly (France), Acquired | Novartis company, developing molecular nuclear medicine theranostics | $56.1M | 73/100 | |
7th | Blueprint Medicines 2008, Cambridge (United States), Acquired | Developer of selective kinase inhibitors for patients with genomically defined cancers | $115M | 72/100 | |
8th | _1548135965397.png?devicePixelRatio=2&height=30&width=30){kind=logo} Kronos Bio 2017, San Mateo (United States), Acquired | Developer of small molecule based therapeutics for cancer treatment | $271M | 72/100 | |
9th |  Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public | Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others | - | 72/100 | |
10th |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 72/100 | |
656th | Gloucester Pharmaceuticals 2002, Cambridge (United States), Acquired | Developer of drugs for the treatment of cancer | $33M | 49/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Gloucester Pharmaceuticals's competitors? Click here to see the top ones
Gloucester Pharmaceuticals's Investments and acquisitions
Gloucester Pharmaceuticals has made no investments or acquisitions yet.
Reports related to Gloucester Pharmaceuticals
Here is the latest report on Gloucester Pharmaceuticals's sector:
News related to Gloucester Pharmaceuticals
•
•
Celgene to Acquire Gloucester PharmaceuticalsBusiness Wire•Dec 07, 2009•Gloucester Pharmaceuticals, Celgene
•
•
•
Gloucester Pharmaceuticals Completes $29 Million FinancingFierce Biotech•Aug 25, 2009•Gloucester Pharmaceuticals, Apple Tree Partners, ProQuest Investments, Prospect Venture Partners and 2 others
•
•
Gloucester Pharmaceuticals Announces New Senior Management TeamBusiness Wire•Jan 28, 2008•Gloucester Pharmaceuticals
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Gloucester Pharmaceuticals
Explore our recently published companies
- DRPU Software - Ghaziabad based, 2008 founded, Public company
- Independent School District 625 - United States based, Funding Raised company
- Scioto Valley Solar One - Funding Raised company
- Beacon Display - Sutton Coldfield based, 1976 founded, Unfunded company
- Lonsen Kiri Chemical Industries - Vadodara based, 2008 founded, Unfunded company
- Pltindustries - Delhi based, 1995 founded, Unfunded company
